// changes done below on July 01 2024 // till here on July 01 2024

The global cell therapy packaging services market is projected to be worth USD 1.1 billion in 2030, growing at a CAGR of ~19%, claims Roots Analysis

Published: August 2021

With the growing pipeline of cell therapy products as potential treatments options for a myriad of diseases, drug developers are likely to collaborate with players offering packaging and logistics services to ensure safe and timely supply to the patients


The global cell therapy packaging market is anticipated to grow at a CAGR of ~19% from 2021-2030, reaching USD 1.1 billion in 2030.

Currently, more than 30 cell therapies have received marketing approvals across the world, while more than 1,000 therapeutic candidates are under clinical evaluation. Moreover, the domain has witnessed an increase of 240% in the investment activity, between 2019- 2020. However, the ultimate success of cell therapies is dependent on the safe and timely delivery of products to the patients. In this regard, several regulatory agencies have established guidelines for cell therapy packaging, storage and transport of cell therapies. 

To order this 170+ page report, which features 70+ figures and 95 tables, please visit this https://www.rootsanalysis.com/reports/cell-therapy-packaging-market.html

Key Market Insights

More than 30 players claim to provide cell therapy packaging products to various pharmaceutical and biotechnology companies across the world
Presently, the market is dominated by large (more than 500 employees) and mid-sized players (51-200 employees), which constitute more than 70% of the total number of packaging product providers, worldwide 

More than 28 companies claim to offer cell therapy packaging services
Presently, ~15 service providers offer secondary packaging for cell therapy products. Further, mid-sized firms and large players capture the highest share within this domain. It is worth mentioning that majority (65%) of the service providers, including Brooks Life Sciences, CSafe Global and WuXi Advanced Therapies are based in North America.

Several partnerships have been established in this domain, since 2016 
The maximum number of deals were inked in 2019; of these, majority were technology / platform integration agreements, followed by service alliances. It is worth noting that the partnership activity within this domain has increased at a CAGR of 66%, between the period 2016-2021.

North America and Europe are anticipated to capture more than 65% of the cell therapy packaging market share by 2030
At present, more than 60% of the revenues are generated from primary packaging of cell therapies; this trend is unlikely to change significantly in short to mid-term. It is worth mentioning that the contract packaging services market in Europe is anticipated to grow at a relatively faster rate (25%), followed by the services market in Asia- Pacific (21%).

You Can Download Free Sample PDF Copy of This Report At:

Key Questions Answered

  • Who are the key players offering cell therapy packaging products and services?
  • What are the key considerations and challenges associated with cell therapy packaging?
  • Which partnership models are commonly adopted by stakeholders in this industry?
  • Which players are likely to partner with cell therapy packaging product and service providers?
  • What factors are likely to influence the evolution of the cell therapy packaging services market?
  • What are the likely future trends in cell therapy packaging services market?
  • How is the current and future opportunity likely to be distributed across key market segments?

The USD 1.1 billion (by 2030) financial opportunity within the cell therapy packaging market has been analyzed across the following segments:

  • Geography
  • North America
  • Europe
  • Asia-Pacific 
  • Rest of the World
  • Type of Therapy
  • T-cell Therapies
  • Dendritic Cell Vaccines
  • Stem Cell Therapies
  • NK Cell Therapies
  • Other ATMPs
  • Package Engineering Design
  • Primary Packaging
  • Secondary Packaging
  • Scale of Operation
  • Clinical
  • Commercial

The research includes detailed profiles of key service providers (listed below) engaged in this domain; each profile features an overview of the company, information on its service portfolio, recent developments, and an informed future outlook.

  • Almac
  • Catalent Pharma Solutions
  • Cryoport Systems
  • Lufthansa Cargo
  • Saint-Gobain
  • Thermo Fisher Scientific
  • West Pharmaceuticals
  • Yourway 

For additional details, please email at sales@rootsanalysis.com


Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry